Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

30 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
HOXA11 DNA methylation--a novel prognostic biomarker in ovarian cancer.
Fiegl H, Windbichler G, Mueller-Holzner E, Goebel G, Lechner M, Jacobs IJ, Widschwendter M. Fiegl H, et al. Among authors: windbichler g. Int J Cancer. 2008 Aug 1;123(3):725-9. doi: 10.1002/ijc.23563. Int J Cancer. 2008. PMID: 18478570 Free article.
Methylated NEUROD1 promoter is a marker for chemosensitivity in breast cancer.
Fiegl H, Jones A, Hauser-Kronberger C, Hutarew G, Reitsamer R, Jones RL, Dowsett M, Mueller-Holzner E, Windbichler G, Daxenbichler G, Goebel G, Ensinger C, Jacobs I, Widschwendter M. Fiegl H, et al. Among authors: windbichler g. Clin Cancer Res. 2008 Jun 1;14(11):3494-502. doi: 10.1158/1078-0432.CCR-07-4557. Clin Cancer Res. 2008. PMID: 18519782 Free article.
Interferon-gamma in combination with carboplatin and paclitaxel as a safe and effective first-line treatment option for advanced ovarian cancer: results of a phase I/II study.
Marth C, Windbichler GH, Hausmaninger H, Petru E, Estermann K, Pelzer A, Mueller-Holzner E. Marth C, et al. Among authors: windbichler gh. Int J Gynecol Cancer. 2006 Jul-Aug;16(4):1522-8. doi: 10.1111/j.1525-1438.2006.00622.x. Int J Gynecol Cancer. 2006. PMID: 16884360 Clinical Trial.
Pooled analysis of prognostic impact of urokinase-type plasminogen activator and its inhibitor PAI-1 in 8377 breast cancer patients.
Look MP, van Putten WL, Duffy MJ, Harbeck N, Christensen IJ, Thomssen C, Kates R, Spyratos F, Fernö M, Eppenberger-Castori S, Sweep CG, Ulm K, Peyrat JP, Martin PM, Magdelenat H, Brünner N, Duggan C, Lisboa BW, Bendahl PO, Quillien V, Daver A, Ricolleau G, Meijer-van Gelder ME, Manders P, Fiets WE, Blankenstein MA, Broët P, Romain S, Daxenbichler G, Windbichler G, Cufer T, Borstnar S, Kueng W, Beex LV, Klijn JG, O'Higgins N, Eppenberger U, Jänicke F, Schmitt M, Foekens JA. Look MP, et al. Among authors: windbichler g. J Natl Cancer Inst. 2002 Jan 16;94(2):116-28. doi: 10.1093/jnci/94.2.116. J Natl Cancer Inst. 2002. PMID: 11792750 Free article.
Different effects of interferons, interleukin-1beta and tumor necrosis factor-alpha in normal (OSE) and malignant human ovarian epithelial cells.
Marth C, Zeimet AG, Herold M, Brumm C, Windbichler G, Müller-Holzner E, Offner F, Feichtinger H, Zwierzina H, Daxenbichler G. Marth C, et al. Among authors: windbichler g. Int J Cancer. 1996 Sep 17;67(6):826-30. doi: 10.1002/(SICI)1097-0215(19960917)67:6<826::AID-IJC12>3.0.CO;2-#. Int J Cancer. 1996. PMID: 8824555 Free article.
30 results